<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>BioScreening.net &#187; ADMET Studies</title>
	<atom:link href="http://www.bioscreening.net/category/news/admet-studies/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.bioscreening.net</link>
	<description>BioScreening news and events</description>
	<lastBuildDate>Thu, 29 Dec 2011 08:21:20 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
		<item>
		<title>TimTec Launches Division of Organic Synthesis and Medicinal Chemistry Contract Research Services</title>
		<link>http://www.bioscreening.net/2010/07/08/timtec-launches-division-of-organic-synthesis-and-medicinal-chemistry-contract-research-services/</link>
		<comments>http://www.bioscreening.net/2010/07/08/timtec-launches-division-of-organic-synthesis-and-medicinal-chemistry-contract-research-services/#comments</comments>
		<pubDate>Fri, 09 Jul 2010 03:39:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[ADMET Studies]]></category>
		<category><![CDATA[Business and Investment]]></category>
		<category><![CDATA[Drug-Like Compounds]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2010/07/08/timtec-launches-division-of-organic-synthesis-and-medicinal-chemistry-contract-research-services/</guid>
		<description><![CDATA[Newark, DE, July 8, 2010 Press Release &#8211; TimTec, LLC is pleased to announce the launching of the new Division that manages Organic Synthesis and Medicinal Chemistry Contract Research Services. The emergence of the division is an evolutionarily progression for TimTecs business development. The company has been known for its expertise in organic chemistry design [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/07/08/timtec-launches-division-of-organic-synthesis-and-medicinal-chemistry-contract-research-services/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TimTec&#8217;s Contract Research Services</title>
		<link>http://www.bioscreening.net/2010/07/08/contract-research-services/</link>
		<comments>http://www.bioscreening.net/2010/07/08/contract-research-services/#comments</comments>
		<pubDate>Thu, 08 Jul 2010 19:22:09 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[ADMET Studies]]></category>
		<category><![CDATA[Drug-Like Compounds]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2010/07/08/contract-research-services/</guid>
		<description><![CDATA[High Quality Organic Synthesis and Medicinal Chemistry Contract Research Services at an Outstanding Value TimTec brings 15 years of expertise in organic chemistry design and supply for drug discovery closer to your supplemental bench-top requirements by launching The Organic Synthesis and Medicinal Chemistry Contract Research Services Division. TimTec scientists have a proven track record of [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/07/08/contract-research-services/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Trends in Drug Research 27th Noordwijkerhout-Camerino-Cyprus Conference Noordwijkerhout, The Netherlands, May 3 &#8211; 8, 2009</title>
		<link>http://www.bioscreening.net/2008/11/27/trends-in-drug-research-27th-noordwijkerhout-camerino-cyprus-conference-noordwijkerhout-the-netherlands-may-3-8-2009/</link>
		<comments>http://www.bioscreening.net/2008/11/27/trends-in-drug-research-27th-noordwijkerhout-camerino-cyprus-conference-noordwijkerhout-the-netherlands-may-3-8-2009/#comments</comments>
		<pubDate>Fri, 28 Nov 2008 02:24:54 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[ADMET Studies]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Targeted Libraries]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/27/trends-in-drug-research-27th-noordwijkerhout-camerino-cyprus-conference-noordwijkerhout-the-netherlands-may-3-8-2009/</guid>
		<description><![CDATA[The Symposium is sponsored by the European Federation of Medicinal Chemistry (EFMC). The Organising and Scientific Committees cordially invite you to attend the 27 edition of this meeting on Trends in Drug Research. The interplay between molecular structure and biological activity is central to contemporary biomedical and translational research, relevant not only to structural biologists [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/27/trends-in-drug-research-27th-noordwijkerhout-camerino-cyprus-conference-noordwijkerhout-the-netherlands-may-3-8-2009/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>WuXi PharmaTech Inks New Three-year Deal with Pfizer</title>
		<link>http://www.bioscreening.net/2008/11/11/wuxi-pharmatech-inks-new-three-year-deal-with-pfizer/</link>
		<comments>http://www.bioscreening.net/2008/11/11/wuxi-pharmatech-inks-new-three-year-deal-with-pfizer/#comments</comments>
		<pubDate>Tue, 11 Nov 2008 18:55:26 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[ADMET Studies]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Drug-Like Compounds]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/11/wuxi-pharmatech-inks-new-three-year-deal-with-pfizer/</guid>
		<description><![CDATA[WuXi PharmaTech (NYSE: WX) has signed a new three-year CRO deal with Pfizer (NYSE: PFE) to collaborate on in vitro ADME (Absorption, Distribution, Metabolism and Excretion) services. Although WuXi has already been providing the services to Pfizer, WuXi said the new agreement â€œstrengthens an already productive relationship.â€ WuXi also provides Pfizer with synthetic chemistry, parallel [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/11/wuxi-pharmatech-inks-new-three-year-deal-with-pfizer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cell-Based Assays: Innovations in Reagents, Technologies &amp; Screening October 23 &#8211; 24, 2008</title>
		<link>http://www.bioscreening.net/2008/10/22/cell-based-assays-innovations-in-reagents-technologies-screening-october-23-24-2008/</link>
		<comments>http://www.bioscreening.net/2008/10/22/cell-based-assays-innovations-in-reagents-technologies-screening-october-23-24-2008/#comments</comments>
		<pubDate>Wed, 22 Oct 2008 20:56:57 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[ADMET Studies]]></category>
		<category><![CDATA[Cell-based Assays]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[HT Screening]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/10/22/cell-based-assays-innovations-in-reagents-technologies-screening-october-23-24-2008/</guid>
		<description><![CDATA[Cell-based assays provide one of the most valuable tools in drug discovery.Â  They are routinely used in target validation, HTS campaigns, structure activity relationship analyses and ADMET studies. Many factors need to be considered in designing, developing and running relevant cell based assays to progress discovery programs.Â  Significant advances continue to be made in assay [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/10/22/cell-based-assays-innovations-in-reagents-technologies-screening-october-23-24-2008/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

